
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon is a leading company in the vision care market with a strong portfolio in contact lenses, lens care solutions, and ocular health products, as well as in surgical equipment and devices for cataract, glaucoma, and refractive eye surgeries. Management expects continued growth in revenue and earnings, driven by new product launches and strong customer demand. The company has strong financials and a solid operating margin. Potential upside drivers include new lens products and an expanding ophthalmic eye drop portfolio, while risks include weaker-than-expected market growth and competition in various business segments. Our investment thesis is that Alcon can sustain mid-single digit revenue growth or better, and we believe the stock is undervalued at its current price.
Bears say
Alcon is seeing decent top-line growth but margin expansion remains a concern due to tougher upcoming comps, tariff impacts, and increased operating spend. While the company is investing heavily in research and development and has a strong product pipeline, the sustainability of this growth remains to be seen in the currently competitive and rapidly changing eyecare market.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares